SuperSonic Imagine Announces Partnership With Unetixs Vascular

Regulatory News :

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814), the highly innovative medical imaging company that invented ShearWave™ Elastography and UltraFast Doppler, announces a partnership with U.S.-based Unetixs Vascular, Inc. to bring SuperSonic Imagine’s technology to more customers in the vascular market.

SuperSonic Imagine’s Aixplorer ultrasound system recently won a Breakthrough Technology award from Premier, Inc., a leading healthcare improvement company in the U.S., and was named as one of Premier’s 2014 Innovators.

"SuperSonic Imagine’s award winning technology is a significant addition to our portfolio of noninvasive vascular solutions.” said Neeraj Jha, CEO of Unetixs Vascular. "Their highly innovative ultrasound system will provide incredible value to our customers that are in need of a fast, reliable ultrasound solution for performing vascular exams.”

"The partnership with Unetixs builds upon the momentum gained from the Premier award,” said Alex Exposito, SuperSonic Imagine Director North America, "and we are excited to be working with a company with such an innovative product line and strong reputation in the vascular space.”

Kurt Kelln, Chief Business Officer and Executive Vice President of Sales & Marketing at SuperSonic Imagine, noted: "Together, we and Unetixs will provide significant value and expertise to the vascular market, the fourth largest ultrasound segment in the United States. This partnership expands our presence and positions us for future growth as we continue to develop unique clinical solutions.”

SuperSonic Imagine’s ultrasound system combines exceptional image quality and UltraFast Doppler to deliver powerful performance across a breadth of vascular applications. Conventional Doppler ultrasound requires two separate exams for imaging and measurement. SuperSonic Imagine’s UltraFast Doppler goes beyond the limits of traditional systems by combining Color Flow Imaging and Pulsed Wave Doppler into one simple exam. This combination provides physicians with exam results simultaneously, which can increase patient throughput and diagnostic confidence, as well as provide a better patient experience. The UltraFast technology has been shown to significantly reduce exam time in long and complex situations such as kidney or liver transplant follow-up. This technology is also used in a wide range of additional clinical situations such as detecting blockages, verifying placement of stents and evaluating artery walls.

Unetixs’s product line consists of noninvasive vascular testing equipment such as the Revo® 1100 and the MultiLab^® Series, ranging from highly advanced systems to self-contained, low-cost diagnostic stations. These diagnostic systems and accessories provide early detection of peripheral arterial disease (PAD), a condition that affects millions of Americans. Without early detection, patients with PAD face a higher risk for stroke, heart attacks, and cardiovascular disease, which is the number one cause of death worldwide.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI. For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.

About Unetixs Vascular Inc.
Unetixs Vascular Inc., a group company of Opto Circuits (India) Ltd, is the leading U.S.- based manufacturer of physiologic vascular instruments. The company designs and manufactures the most in-depth line of technically advanced instrumentation for diagnostic vascular testing. For over 20 years, Unetixs has listened to its customers and provided the equipment and training that best meets their needs. Find out more by visiting www.unetixs.com.